Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Buzz Mills who wrote (225)	11/19/1997 4:19:00 PM
From: johny	Respond to of 2068

These laywers are like vultures, the thought that the only ones who will get any compensation will be the laywers themselves and not the shareholders makes me sick. When will the shareholders realise that they are merely beeing manipulated by these firms? Argh..

To: Buzz Mills who wrote (225)	11/19/1997 4:54:00 PM
From: Naggrachi	Read Replies (1) \| Respond to of 2068

There was no reason to post the PR regarding the s/h lawsuit twice, if at all. A while back, a law firm was advertising on these threads and I thought you were doing likewise. As far as OXHP, on Taking Stock, this morning on CNBC, an analyst thought that the health care companies have been beat'n down and he thought it was a good time to enter. His recommendation, howeever, was Aetna with a price target of $110. I agree with the analyst above, this is a good entry point for most healthcare companies. Better to buy out of favor stocks which have pretty much bottomed out than get into some hot sector that is overvalued and pay for it with your hard earned money. A case in point, the oil drillers sector. Zead